{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:10:35Z","timestamp":1791119435421,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.humpath.2014.04.026","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T13:35:16Z","timestamp":1408800916000},"page":"2334-2340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Chung-Ta","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Teh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.humpath.2014.04.026_bb0005","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/modpathol.3800682","article-title":"Neoplasms of the liver","volume":"20","author":"Goodman","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0010","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/1097-0142(19911101)68:9<2051::AID-CNCR2820680934>3.0.CO;2-M","article-title":"Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma","volume":"68","author":"Altaee","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2014.04.026_bb0015","series-title":"WHO classification of tumours of the digestive system","author":"Bosman","year":"2010"},{"key":"10.1016\/j.humpath.2014.04.026_bb0020","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2014.04.026_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.humpath.2014.04.026_bb0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PPO.0b013e31819e3312","article-title":"Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma","volume":"15","author":"Jiang","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.humpath.2014.04.026_bb0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00268-001-0291-1","article-title":"Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma","volume":"26","author":"Suzuki","year":"2002","journal-title":"World J Surg"},{"issue":"11 Suppl","key":"10.1016\/j.humpath.2014.04.026_bb0040","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.cgh.2009.08.023","article-title":"Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms","volume":"7","author":"Sirica","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0045","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cncr.10398","article-title":"Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma","volume":"94","author":"Matsumura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2014.04.026_bb0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hep.20031","article-title":"MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type","volume":"39","author":"Shibahara","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2014.04.026_bb0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1245\/s10434-013-3286-x","article-title":"Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis","volume":"21","author":"Ruys","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<316::AID-GCC2>3.0.CO;2-0","article-title":"HMGIC expression in human adult and fetal tissues and in uterine leiomyomata","volume":"25","author":"Gattas","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2014.04.026_bb0065","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1158\/0008-5472.CAN-03-1855","article-title":"Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity","volume":"64","author":"Miyazawa","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2014.04.026_bb0070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mc.20235","article-title":"HMGA2 overexpression in non\u2013small cell lung cancer","volume":"46","author":"Meyer","year":"2007","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.humpath.2014.04.026_bb0075","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1158\/1078-0432.CCR-07-4667","article-title":"Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family","volume":"14","author":"Motoyama","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2014.04.026_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/modpathol.2008.140","article-title":"HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma","volume":"22","author":"Hristov","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0b013e3181be5d72","article-title":"HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes","volume":"34","author":"Wei","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0090","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/modpathol.2010.49","article-title":"HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma","volume":"23","author":"Mahajan","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejso.2011.01.004","article-title":"Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer","volume":"37","author":"Yang","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0100","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1158\/1078-0432.CCR-10-2542","article-title":"Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers","volume":"17","author":"Wang","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2014.04.026_bb0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2559.2011.04121.x","article-title":"HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma","volume":"60","author":"Piscuoglio","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.04.026_bb0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00428-012-1228-9","article-title":"HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases","volume":"460","author":"Hetland","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2014.04.026_bb0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1477-7819-10-92","article-title":"Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder","volume":"10","author":"Zou","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2012.05.001","article-title":"The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasiveness","volume":"44","author":"Rizzi","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.humpath.2012.05.013","article-title":"Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis","volume":"44","author":"Romero-Perez","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0130","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/his.12084","article-title":"Diagnostic value of HMGAs, p53 and \u03b2-catenin in discriminating adenocarcinoma from adenoma or reactive atypia in ampulla and common bile duct biopsies","volume":"62","author":"Zakharov","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.04.026_bb0135","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.humpath.2012.08.003","article-title":"High mobility group AT-hook 2 is overexpressed in hepatoblastoma","volume":"44","author":"Lee","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbagrm.2009.11.007","article-title":"HMGA and cancer","volume":"1799","author":"Fedele","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2014.04.026_bb0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.scr.2012.11.002","article-title":"HMGA2 regulates the in vitro aging and proliferation of human umbilical cord blood\u2013derived stromal cells through the mTOR\/p70S6K signaling pathway","volume":"10","author":"Yu","year":"2013","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.humpath.2014.04.026_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cell.2008.09.017","article-title":"HMGA2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression","volume":"135","author":"Nishino","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2014.04.026_bb0155","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/15216540701488358","article-title":"INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions","volume":"59","author":"C\u00e1nepa","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.humpath.2014.04.026_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/path.2345","article-title":"Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis","volume":"215","author":"Sasaki","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0165","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1309\/AJCP35FDCAVANWMM","article-title":"Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray\u2013based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas","volume":"130","author":"Karamitopoulou","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2014.04.026_bb0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0031-1276646","article-title":"Genetics of hepatobiliary carcinogenesis","volume":"31","author":"Nault","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.humpath.2014.04.026_bb0175","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1478-3231.2005.01106.x","article-title":"p53 mutations in human cholangiocarcinoma: a review","volume":"25","author":"Khan","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2014.04.026_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2008.08.024","article-title":"Prognostic molecular markers in cholangiocarcinoma: a systematic review","volume":"45","author":"Briggs","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2014.04.026_bb0185","author":"Washington"},{"key":"10.1016\/j.humpath.2014.04.026_bb0190","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1007\/s00268-007-9194-0","article-title":"Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma","volume":"31","author":"Shimada","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/j.humpath.2014.04.026_bb0195","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/PAS.0b013e31827332b0","article-title":"Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification","volume":"37","author":"Akiba","year":"2013","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714003244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714003244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T10:25:18Z","timestamp":1538303118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817714003244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0046817714003244"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2014.04.026","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2014.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}